Navigation Links
New Disinfection Technology Expected To Combat Deadly CRE Threat
Date:3/21/2013

SAN FRANCISCO, March 21, 2013 /PRNewswire/ -- San Francisco-based Medizone International (MZEI:OB) (MZEI:QB), announced today that its patented, peer-reviewed disinfection system is 'more than capable' of eliminating CRE from hospital and health care environments.

Medizone CEO Edwin Marshall stated, "Given the growing public, media and health sector interest in the emergence of CRE  (Carbapenem-resistant Enterobacteriaceae) in hospitals as a highly antibiotic resistant cause of hospital acquired infections (HAI), we felt that it was important to make public the anticipated effectiveness of AsepticSure with CRE."

Dr Michael E. Shannon M.A ., M.Sc., M.D. President and Director of Medical Affairs for Medizone, added, "Although we are not permitted to conduct research on extremely dangerous pathogens such as CRE, I can say unequivocally that we have absolutely no difficulty destroying all of its relatives including Klebsiella and E coli which are commonly cited as examples of Enterobacteriaceae.

"These bacteria are among the easiest for our AsepticSure system to eliminate in that when we achieve a 6 log (99.9999%) kill with MRSA we are usually looking at a 7 log kill for Klebsiella and E coli (99.99999%). I therefore have no doubt that CRE can be completely eradicated from any contaminated space using our AsepticSure system."

AsepticSure has recently been trialed successfully at Belleville General Hospital in Ontario, Canada, and is also the recipient of a prestigious WHO award for innovation.

For press information on Medizone International, please contact:
Bruce Smeaton , Investor Relations, Medizone International, Inc.
T: 001-415-331-0202    E: bruce@medizoneint.com

Medizone International, Inc. is engaged in initial production and sales of its modular design AsepticSure® Decontamination Systems. Decontamination to the sterilization standard of >6 log (99.9999%) is obtainable within hospitals, airlines, cruise ships, long term care facilities, food processing plants, clean room manufacturing facilities, schools and other critical infrastructure.

This Press Release may contain certain forward looking statements that could involve substantial risks and uncertainties, including, but not limited to, the results of ongoing clinical studies, economic conditions, product and technology development, production efficiencies, product demand, competitive products, competitive environment, successful testing and government regulatory issues. Additional risks are identified in the company's filings made with the Securities and Exchange Commission.

For more information, visit: www.medizoneint.com


'/>"/>
SOURCE Medizone International, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. PDI Signs Agreement with HealthTrust for Surface Disinfection Products
2. ARAMARK Healthcare Offered Disinfection Robot Revolutionizes Hospital Sanitation Practices on The Doctors
3. JDRF Announces Research Collaboration with Dexcom, Inc. to Develop "Smart Transmitter" Technology to Accelerate Artificial Pancreas Studies
4. Fujitsu to Showcase Radiation-Hardened RFID Using FRAM Technology at Interphex 2012 in New York City, Booth #2430
5. SolutionStart Corp. Announces John Karagiannis as Vice President of Technology
6. Ultra Clean to Present at the Jefferies 2012 Global Technology, Media & Telcom Conference
7. Amarantus BioSciences to Present at the New York Biotechnology Association (NYBA) 21st Annual Meeting on May 2nd, 2012
8. Johnson & Johnson (China) Investment Ltd. Acquires Guangzhou Bioseal Biotechnology Co., Ltd.
9. DURECT Announces Issuance of U.S. Patents Covering ORADUR® Technology
10. Remedy Informatics Named "Cool Vendor" in Life Sciences by Leading Technology Analyst Firm
11. Pharmaceutics International, Inc. (Pii) Supports University Pharmaceutical Technology Education and Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/28/2017)... Sept. 28, 2017 Hill-Rom Holdings, Inc. (NYSE: ... conference call and webcast on Friday, November 3, 2017, ... and ending at approximately 8:30 a.m. (CDT) / 9:30 ... company,s 2017 financial performance and guidance for 2018, Hill-Rom ... to enhance operational performance, and long-range financial outlook through ...
(Date:9/27/2017)... and NEW YORK , Sept. 27, 2017  DarioHealth ... and big data solutions, today announced that its MyDario product is expected ... local TV listings for when The Dr. Oz Show airs in your ... The nine-time Emmy ... ...
(Date:9/23/2017)... , Sept. 22, 2017 Janssen Biotech, ... complete response letter from the U.S. Food and Drug ... approval of sirukumab for the treatment of moderately to ... indicates additional clinical data are needed to further evaluate ... to severely active RA. ...
Breaking Medicine Technology:
(Date:10/13/2017)... N.J. (PRWEB) , ... October 13, 2017 , ... The ... Holly Day Market. Featuring a collection of specialty vendors and unique items from across ... personalized and quality-focused health and wellness services offered by the VNA. The boutique ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... ... DevOps and Agile Software Development, has been awarded a contract by the Center ... Purchase Agreement (BPA) aims to accelerate the enterprise use of Agile methodologies in ...
(Date:10/12/2017)... LA (PRWEB) , ... October 12, 2017 , ... Planet ... in the U.S., announced today its plans to open a flagship location in Covington, ... occupy the former Rooms To Go store next to Office Depot in the Holiday ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information about the technology: , ... to enable prevention of a major side effect of chemotherapy in children. Cisplatin ... patients. For cisplatin, hearing loss is FDA listed on-label as a dose limiting ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... been named one of Michigan’s 2017 Best and Brightest in Wellness® by Best ... in Wellness® awards program on Friday, Oct. 20 from 7:30 a.m. to 2 ...
Breaking Medicine News(10 mins):